Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers

Objective: Two single-center, four-way, single-dose, crossover studies assessed the systemic exposure, systemic pharmacodynamics (PD), and safety profile of the closed triple fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) therapy compared with dual therapies. These are the first studies wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Brealey, Noushin, Gupta, Ashutosh, Renaux, Jessica, Mehta, Rashmi, Allen, Ann, Henderson, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531525/
https://www.ncbi.nlm.nih.gov/pubmed/26227101
http://dx.doi.org/10.5414/CP202390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531525/
https://www.ncbi.nlm.nih.gov/pubmed/26227101
http://dx.doi.org/10.5414/CP202390

Ejemplares similares